Functional Dyspepsia and Food: Immune Overlap with Food Sensitivity Disorders.


Journal

Current gastroenterology reports
ISSN: 1534-312X
Titre abrégé: Curr Gastroenterol Rep
Pays: United States
ID NLM: 100888896

Informations de publication

Date de publication:
14 Aug 2020
Historique:
entrez: 16 8 2020
pubmed: 17 8 2020
medline: 4 5 2021
Statut: epublish

Résumé

Functional dyspepsia (FD) is a chronic functional gastrointestinal disorder characterised by upper gastrointestinal symptoms. Here, we aimed to examine the evidence for immune responses to food in FD and overlap with food hypersensitivity conditions. A feature of FD in a subset of patients is an increase in mucosal eosinophils, mast cells, intraepithelial cytotoxic T cells and systemic gut-homing T cells in the duodenum, suggesting that immune dysfunction is characteristic of this disease. Rates of self-reported non-celiac wheat/gluten sensitivity (NCW/GS) are higher in FD patients. FD patients commonly report worsening symptoms following consumption of wheat, fermentable oligosaccharides, disaccharides, monosaccharides, or polyols (FODMAPs), high-fat foods and spicy foods containing capsaicin. Particularly, wheat proteins and fructan in wheat may drive symptoms. Immune mechanisms that drive responses to food in FD are still poorly characterised but share key effector cells to common food hypersensitivities including non-IgE-mediated food allergy and eosinophilic oesophagitis.

Identifiants

pubmed: 32797313
doi: 10.1007/s11894-020-00789-9
pii: 10.1007/s11894-020-00789-9
doi:

Substances chimiques

Dietary Fats 0
Disaccharides 0
Monosaccharides 0
Oligosaccharides 0
Polymers 0
polyol 0
Immunoglobulin E 37341-29-0
Capsaicin S07O44R1ZM

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

51

Auteurs

Jennifer Pryor (J)

School of Biomedical Sciences & Pharmacy, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia.
Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Newcastle, NSW, Australia.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.

Grace L Burns (GL)

School of Biomedical Sciences & Pharmacy, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia.
Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Newcastle, NSW, Australia.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.

Kerith Duncanson (K)

Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Newcastle, NSW, Australia.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
School of Medicine and Public Health, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia.

Jay C Horvat (JC)

School of Biomedical Sciences & Pharmacy, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.

Marjorie M Walker (MM)

Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Newcastle, NSW, Australia.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
School of Medicine and Public Health, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia.

Nicholas J Talley (NJ)

Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Newcastle, NSW, Australia.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
School of Medicine and Public Health, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia.

Simon Keely (S)

School of Biomedical Sciences & Pharmacy, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia. simon.keely@newcastle.edu.au.
Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Newcastle, NSW, Australia. simon.keely@newcastle.edu.au.
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia. simon.keely@newcastle.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH